ConductScience.org, home

Paper39348357

Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.

Ajadee A and 7 others. PLoS One, 2024. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma. Papers, record 39348357. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39348357

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Screening of differential gene expression patterns through survival analysis for diagnosis, prognosis and therapies of clear cell renal cell carcinoma.
PubMed
Journal
PLoS One
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.04, provisional
iCite
Revised in PubMed
2026-09-23
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ajadee AAlvira
2Mahmud SSabkat
3Hossain MBMd Bayazidhttps://orcid.org/0000-0001-7634-2785
4Ahmmed RReaz
5Ali MAMd Ahad
6Reza MSMd Selim
7Sarker SKSaroje Kumar
8Mollah MNHMd Nurul Haquehttps://orcid.org/0000-0002-3883-3396

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Renal CellMajor topic
Kidney NeoplasmsMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Humans
Prognosis
Survival Analysis
Gene Expression Profiling
Biomarkers, Tumor
Protein Interaction Maps
Gene Regulatory Networks
Transcriptome

Source PubMed

Download CSV of topics

References172

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129159069Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).Genom Data2017https://conductscience.org/library/papers/29159069PubMed
233015999TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma.FEBS Open Bio2020https://conductscience.org/library/papers/33015999PubMed
336310399The cross-talk between Abl2 tyrosine kinase and TGFβ1 signalling modulates the invasion of clear cell Renal Cell Carcinoma cells.FEBS Lett2023https://conductscience.org/library/papers/36310399PubMed
434884615Cytochrome P450 Enzymes and Drug Metabolism in Humans.Int J Mol Sci2021https://conductscience.org/library/papers/34884615PubMed
530371825PubChem 2019 update: improved access to chemical data.Nucleic Acids Res2019https://conductscience.org/library/papers/30371825PubMed
626221251Screening feature genes of osteosarcoma with DNA microarray: a bioinformatic analysis.Int J Clin Exp Med2015https://conductscience.org/library/papers/26221251PubMed
735442707A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.Sci Transl Med2022https://conductscience.org/library/papers/35442707PubMed
832038957Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value.Transl Androl Urol2019https://conductscience.org/library/papers/32038957PubMed
926790128Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma.Cancer Sci2016https://conductscience.org/library/papers/26790128PubMed
1035121728PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.Cell Death Dis2022https://conductscience.org/library/papers/35121728PubMed
1129264942MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data.Epigenomics2018https://conductscience.org/library/papers/29264942PubMed
1235853872Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma.Cell Discov2022https://conductscience.org/library/papers/35853872PubMed
1336176391A metabolic reprogramming-related prognostic risk model for clear cell renal cell carcinoma: From construction to preliminary application.Front Oncol2022https://conductscience.org/library/papers/36176391PubMed
1437576399TLR4 predicts patient prognosis and immunotherapy efficacy in clear cell renal cell carcinoma.J Cancer2023https://conductscience.org/library/papers/37576399PubMed
1519959715Uromodulin levels associate with a common UMOD variant and risk for incident CKD.J Am Soc Nephrol2010https://conductscience.org/library/papers/19959715PubMed
1627713636Clinical use of cabozantinib in the treatment of advanced kidney cancer: efficacy, safety, and patient selection.Onco Targets Ther2016https://conductscience.org/library/papers/27713636PubMed
1718587261Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy.Urol Int2008https://conductscience.org/library/papers/18587261PubMed
1835994213Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.Discov Oncol2022https://conductscience.org/library/papers/35994213PubMed
1937353178Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone.Crit Rev Oncol Hematol2023https://conductscience.org/library/papers/37353178PubMed
2037893423Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.Medicina (Kaunas)2023https://conductscience.org/library/papers/37893423PubMed

See all 172 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42886687Disclosing pathogenic processes of monkeypox (MPOX) and drug repurposing through host-transcriptomics analysis.PLoS Negl Trop Dis2026https://conductscience.org/library/papers/42886687PubMed
41839687Genetic underpinnings of type-2 diabetes (T2D) with colorectal cancer (CRC): In-silico discovery of common molecular signatures, pathogenetic processes and therapeutic candidates.J Genet Eng Biotechnol2026https://conductscience.org/library/papers/41839687PubMed
40370100In-silico discovery of type-2 diabetes-causing host key genes that are associated with the complexity of monkeypox and repurposing common drugs.Brief Bioinform2025https://conductscience.org/library/papers/40370100PubMed
40127075Exploring common genomic biomarkers to disclose common drugs for the treatment of colorectal cancer and hepatocellular carcinoma with type-2 diabetes through transcriptomics analysis.PLoS One2025https://conductscience.org/library/papers/40127075PubMed
40114841In silico research of coagulation- and fibrinolysis-related genes for predicting prognosis of clear cell renal cell carcinoma.Transl Androl Urol2025https://conductscience.org/library/papers/40114841PubMed
40025145Screening of common genomic biomarkers to explore common drugs for the treatment of pancreatic and kidney cancers with type-2 diabetes through bioinformatics analysis.Sci Rep2025https://conductscience.org/library/papers/40025145PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data9

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GEOGSE16441GEO
GEOGSE53757GEO
GEOGSE66270GEO
GEOGSE66272GEO
GEOGSE16449GEO
GEOGSE76351GEO
GEOGSE66271GEO
GEOGSE71963GEO
GEOGSE36895GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39348357

GET https://conductscience.org/api/papers/v1/39348357/references?page=2